Page last updated: 2024-09-04

bazedoxifene and Hot Flashes

bazedoxifene has been researched along with Hot Flashes in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (7.55)	29.6817
2010's	48 (90.57)	24.3611
2020's	1 (1.89)	2.80

Authors

Authors	Studies
Bi, B; Jiang, Y; Ruan, F; Shi, Y	1
Abraham, L; Bobula, J; Bushmakin, AG; Komm, BS; Pinkerton, JV	1
Abraham, L; Bobula, J; Bushmakin, AG; Komm, BS; Lavenberg, J; Pinkerton, JV	1
Komm, BS; Lavenberg, J; Pan, K; Pickar, JH	1
Pinkerton, JV	1
Conner, EA; Pinkerton, JV	1
Komm, BS; Mirkin, S; Pinkerton, JV	1
Komm, BS; Mirkin, S	1
Bushmakin, AG; Cappelleri, JC; Chines, AA; Mirkin, S; Pinkerton, JV; Racketa, J	1
Abraham, L; Chines, AA; Mirkin, S; Pan, K; Pinkerton, JV; Racketa, J; Ryan, KA	1
Gallagher, JC; Tella, SH	1
Abraham, L; Bushmakin, AG; Cappelleri, JC; Chines, AA; Mirkin, S; Pinkerton, JV; Racketa, J; Shi, H	1
Chandran, AB; Komm, BS; Mirkin, S; Ryan, KA	1
Pinkerton, JV; Thomas, S	1
Abraham, L; Bushmakin, AG; Cappelleri, JC; Mirkin, S; Pinkerton, JV	1
Komm, B; Mirkin, S; Pickar, JH	1
Jordan, VC	1
Abraham, L; Komm, BS; Messig, M; Mirkin, S; Pinkerton, JV; Ryan, KA	1
Jenkins, SN; Komm, BS; Mirkin, S	1
Carris, N; Kutner, S; Reilly-Rogers, S	1
Komm, BS; Mirkin, S; Pan, K; Skouby, SO; Thompson, JR	1
Currie, H; Dragon, E; Mikkola, TS; Palacios, S	1
Raney, EC	1
Assaf, AR; Black, D; Boucher, M; Komm, BS; Messig, M; Mirkin, S; Yu, CR	1
Arias, L; Komm, BS; Lavenberg, J; Mirkin, S; Palacios, S; Pan, K	1
Karel, L; Santoro, N; Umland, EM	1
Komm, BS; Mirkin, S; Pickar, JH; Pinkerton, JV; Ryan, KA; Yu, CR	1
Abraham, L; Bushmakin, AG; Cappelleri, JC; Komm, BS; Pinkerton, JV	1
Kagan, R; Komm, BS; Lavenberg, J; Pinkerton, JV; Ryan, KA; Yu, CR	1
Hadji, P; Komm, BS; Mirkin, S; Ryan, KA; Yu, CR	1
Archer, DF; Freeman, EW; Komm, BS; Mirkin, S; Pinkerton, JV; Ryan, KA; Yu, CR	1
Abraham, L; Bushmakin, AG; Dragon, E; Komm, BS; Pinkerton, JV	1
Crider, M; Hill, DA; Hill, SR	1
Gillespie, JA; Parish, SJ	1
Mitwally, MF	1
Constantine, G; Dorin, MH; Gass, MLS; Lobo, RA; Pickar, JH; Pinkerton, JV; Ronkin, S	1
Bobula, J; Mirkin, S; Olivier, S; Pickar, JH; Utian, W; Yu, H	1
Brown, JP; Chines, AA; Codreanu, C; de Villiers, TJ; Kelepouris, N; Levine, AB; Lips, P; Palacios, S; Sawicki, AZ	1
Archer, DF	1
Mirkin, S; Pickar, JH	1
Lindsay, R	1
Pinkerton, JV; Stovall, DW	1
Bachmann, G; Constantine, GD; Crosby, U; Feldman, RA; Ronkin, S	1
Bouchard, C	1
Levine, JP	1
Pinkerton, JV; Stovall, DW; Tanner-Kurtz, K	1
Ohleth, K; Taylor, HS	1
Kagan, R	1
Hadji, P	1
Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J	1
Chines, AA; Mirkin, S; Racketa, J; Yu, H	1
Calaf Alsina, J; Coronado Martín, PJ	1
Chaki, O	1

Reviews

27 review(s) available for bazedoxifene and Hot Flashes

Article	Year
Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:10 Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators	2022
Tissue-selective Estrogen Complex for Menopausal Hormone Therapy. Clinical obstetrics and gynecology, 2018, Volume: 61, Issue:3 Topics: Bone Density; Breast Density; Dyspareunia; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Selective Estrogen Receptor Modulators; Sleep Initiation and Maintenance Disorders; Thromboembolism	2018
Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators. Climacteric : the journal of the International Menopause Society, 2019, Volume: 22, Issue:2 Topics: Adult; Aged; Atrophy; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina	2019
Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:6 Topics: Animals; Atrophy; Estrogens, Conjugated (USP); Female; Gene Expression; Hot Flashes; Humans; Indoles; Lipid Metabolism; Osteoporosis, Postmenopausal; Quality of Life; Selective Estrogen Receptor Modulators; Sleep; Vagina; Venous Thromboembolism; Vulva	2013
Tissue-selective estrogen complexes for postmenopausal women. Maturitas, 2013, Volume: 76, Issue:3 Topics: Breast; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Sleep; Uterus; Vaginal Diseases	2013
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:17 Topics: Animals; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis; Selective Estrogen Receptor Modulators	2013
Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms. Maturitas, 2014, Volume: 77, Issue:1 Topics: Estrogens; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators	2014
Use of SERMs for treatment in postmenopausal women. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene	2014
Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Women's health (London, England), 2014, Volume: 10, Issue:2 Topics: Bone Density Conservation Agents; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Sweating; Treatment Outcome; Vasomotor System	2014
Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss. Steroids, 2014, Volume: 90 Topics: Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis, Postmenopausal	2014
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10 Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System	2014
Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide. Maturitas, 2015, Volume: 80, Issue:4 Topics: Adult; Amenorrhea; Bone Density; Breast; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Hemorrhage; Venous Thromboembolism	2015
Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause. Pharmacotherapy, 2016, Volume: 36, Issue:5 Topics: Drug Combinations; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis	2016
Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016, Dec-01, Volume: 94, Issue:11 Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride	2016
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Postgraduate medicine, 2017, Volume: 129, Issue:3 Topics: Age Factors; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Drug Administration Routes; Drug Combinations; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sleep Wake Disorders; Time Factors; Vagina	2017
Bazedoxifene: a selective estrogen-receptor modulator. Women's health (London, England), 2008, Volume: 4, Issue:4 Topics: Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Women's Health	2008
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms. Drugs & aging, 2010, Jul-01, Volume: 27, Issue:7 Topics: Aged; Animals; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators	2010
Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex. Menopause international, 2010, Volume: 16, Issue:3 Topics: Amenorrhea; Bone Density; Breast; Clinical Trials, Phase III as Topic; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Pain; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators	2010
Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:2 Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Collagen Type I; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Peptides; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vaginal Diseases	2011
Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:12 Topics: Animals; Clinical Trials as Topic; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis, Postmenopausal; Postmenopause; Selective Estrogen Receptor Modulators; Treatment Outcome	2010
Treating menopausal symptoms with a tissue-selective estrogen complex. Gender medicine, 2011, Volume: 8, Issue:2 Topics: Atrophy; Body Mass Index; Climacteric; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; Vasomotor System; Vulva; Women's Health	2011
Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:4 Topics: Bone and Bones; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Multicenter Studies as Topic; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Treatment Outcome; Women's Health	2012
The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms. Journal of women's health (2002), 2012, Volume: 21, Issue:9 Topics: Bone Density; Breast; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Postmenopause; Selective Estrogen Receptor Modulators	2012
The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Fractures, Bone; Hot Flashes; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spinal Fractures; Tetrahydronaphthalenes	2012
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:5 Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva	2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action]. Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism	2013
[Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene]. Clinical calcium, 2007, Volume: 17, Issue:1 Topics: Animals; Breast Neoplasms; Cholesterol; Female; Fractures, Spontaneous; Hot Flashes; Humans; Indoles; Osteoporosis, Postmenopausal; Rats; Selective Estrogen Receptor Modulators; Uterus	2007

Trials

20 trial(s) available for bazedoxifene and Hot Flashes

Article	Year
Time to transient and stable reductions in hot flush frequency in postmenopausal women using conjugated estrogens/bazedoxifene. Menopause (New York, N.Y.), 2017, Volume: 24, Issue:9 Topics: Adult; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Time Factors	2017
Hot flush frequency and severity at baseline as predictors of time to transient and stable treatment success: pooled analysis of two CE/BZA studies. Menopause (New York, N.Y.), 2017, Volume: 24, Issue:12 Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators	2017
Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study. Menopause (New York, N.Y.), 2018, Volume: 25, Issue:3 Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Ultrasonography	2018
Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3 Topics: Adult; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Models, Statistical; Placebos; Postmenopause; Sleep Wake Disorders; Treatment Outcome	2014
Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3 Topics: Double-Blind Method; Estrogens, Conjugated (USP); Female; Health Status; Hot Flashes; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Quality of Life; Sleep; Sleep Wake Disorders; Surveys and Questionnaires	2014
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials. Journal of women's health (2002), 2014, Volume: 23, Issue:1 Topics: Dose-Response Relationship, Drug; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Health Status; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome	2014
Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:8 Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Selective Estrogen Receptor Modulators; Surveys and Questionnaires; Treatment Outcome	2014
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Maturitas, 2014, Volume: 78, Issue:3 Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases	2014
Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:6 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Postmenopause; Quality of Life; Treatment Outcome	2015
The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trials. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:4 Topics: Adult; Aged; Body Mass Index; Body Weight; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators	2016
Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population. Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:3 Topics: Adult; Aged; Atrophy; Body Mass Index; Bone Density; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Latin America; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Vagina; Vulva	2016
Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:6 Topics: Black or African American; Bone Density; Double-Blind Method; Dyspareunia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hispanic or Latino; Hot Flashes; Humans; Hydrogen-Ion Concentration; Indoles; Middle Aged; Minority Groups; Placebos; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; White People	2016
Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:10 Topics: Decision Support Techniques; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Sleep Wake Disorders; Treatment Outcome; United Kingdom; United States	2016
CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis. Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:5 Topics: Aged; Bone Density; Bone Remodeling; Collagen Type I; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Europe; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Quality of Life; Selective Estrogen Receptor Modulators; Treatment Outcome; United States; Vasomotor System	2016
Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. Journal of women's health (2002), 2016, Volume: 25, Issue:11 Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; United States; Vasomotor System	2016
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertility and sterility, 2009, Volume: 92, Issue:3 Topics: Adult; Aged; Atrophy; Carbohydrate Metabolism; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Homocysteine; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Outpatients; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina	2009
Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women. Maturitas, 2009, Aug-20, Volume: 63, Issue:4 Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Linear Models; Middle Aged; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sleep; Surveys and Questionnaires	2009
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Hot Flashes; Humans; Indoles; Middle Aged; Muscle Cramp; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thrombosis	2011
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5 Topics: Bone and Bones; Bone Density Conservation Agents; Female; Hot Flashes; Humans; Indoles; Lipids; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2011
Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:2 Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Treatment Outcome	2013

Other Studies

6 other study(ies) available for bazedoxifene and Hot Flashes

Article	Year
A(nother) scientific strategy to prevent breast cancer in postmenopausal women by enhancing estrogen-induced apoptosis? Menopause (New York, N.Y.), 2014, Volume: 21, Issue:10 Topics: Aged; Apoptosis; Breast Neoplasms; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Hysterectomy; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Women's Health	2014
What new therapeutic options exist for the relief of menopausal symptoms? JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:7 Topics: Atrophy; Bone Density; Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Vaginal Diseases; Vulvar Diseases	2015
Timing and persistence of effect of conjugated estrogens/bazedoxifene in postmenopausal women. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:11 Topics: Bone Density; Bone Density Conservation Agents; Cell Count; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Middle Aged; Postmenopause; Quality of Life; Sleep; Time Factors; Vagina	2016
Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women. Maturitas, 2016, Volume: 94 Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Models, Psychological; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Behavior	2016
Selective estrogen receptor modulators and their effects on hot flashes: a dilemma. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5 Topics: Female; Hot Flashes; Humans; Indoles; Postmenopause; Selective Estrogen Receptor Modulators	2011
Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms. Drugs, 2011, Sep-10, Volume: 71, Issue:13 Topics: Adult; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasomotor System	2011